J&J's Janssen R&D LLC buys Aragon Pharmaceuticals
Johnson & Johnson's Janssen R&D LLC has acquired closely held Aragon Pharmaceuticals Inc. (hormonally-driven cancer therapeutics) for $650mm in cash up front, plus earn-outs upon reaching development milestones of up to $350mm.
- Acquisition of Private Biotech
- Full Acquisition
- Includes Earnout
- Payment Includes Cash
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com